A Case of Plasmodium Falciparum Malaria in a 28-Year-Old Man Referred to the Emergency Department
Iranian Journal of Emergency Medicine,
Vol. 2 No. 1 (2015),
28 Esfand 2015
,
Page 54-57
https://doi.org/10.22037/ijem.v2i1.7802
Abstract
Malaria is a parasite disease associated with fever and about half of the world population is at risk. According to the reports of World Organization Center (WHO), about 207 million cases of clinical manifestation of malaria happened in 2012, which followed with 627,000 deaths. Considering to presence of malaria-endemic areas in Iran, several efforts have been performed recently to control and eradication of malaria in terms of country programs. Despite of reducing the incidence rate, few cases of malaria have been reported yet. Therefore, the present report was done with the aim of remembering the model of referring, clinical signs, as well as diagnostic and therapeutic procedures of patients suffered malaria- مالاریا، فالسیپاروم؛ هپاتیت؛ زردی؛ بخش اورژانس
How to Cite
References
Cunningham J, Gatton ML. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 5 (2013). Geneva: World Health Organization, 2014 September. Report No.: 9241507551.
Organization WH. World malaria report 2012. Geneva: World Health Organization, 2012 9789241564403.
Murray CJ, Rosenfeld LC, Lim SS, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet. 2012;379(9814):413-31.
Sargolzaie N, Salehi M, Kiani M, Sakeni M, Hasanzehi A. Malaria Epidemiology in Sistan and Balouchestan Province during April 2008-March 2011, Iran. Zahedan J Res Med Sci. 2014;16(4):41-3.
Halimi M, Farajzadeh M, Delavari M, Bagheri H. Climatic Survey of Malaria Incidence in Iran during 1971-2005. Journal of School of Public Health and Institute of Public Health Research. 2014;12(1):1-11.
Raeisi A, Nikpoor F , Ranjbar Kahkha M, Faraji L. The trend of Malaria in I.R. Iran from 2002 to 2007. Hakim. 2009;12(1):35-41.
Reyburn H, Mbatia R, Drakeley C, et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA. 2005;293(12):1461-70.
Korenromp E, Miller J, Nahlen B, Wardlaw T, Young M. World malaria report 2005. Geneva: World Health Organization and UNICEF, 2005 924159319 9.
Murphy SC, Shott JP, Parikh S, Etter P, Prescott WR, Stewart VA. Malaria diagnostics in clinical trials. The American journal of tropical medicine and hygiene. 2013;89(5):824-39.
Edrissian GH. The Trend of Malaria Drug Resistance in Iran during 1983-2001. J School Public Health. 2004;2(3):83-93.
Tarimo D, Leshabari M, Maddox G, Shelton A, McCurdy S. Malaria treatment practices in the transition from sulfadoxine-pyrimethamine to artemether-lumefantrine: A pilot study in Temeke municipality, Tanzania. East Afr J Public Health. 2014;10(3):550-60.
Manning L, Laman M, Law I, et al. Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One. 2011;6(12):e29203.
- Abstract Viewed: 991 times
- PDF (فارسی) Downloaded: 368 times
- HTML (فارسی) Downloaded: 106 times